A pharmaceutical company that wants to use data to speed up its research processes. A biotech player that wants help in validating its systems. A hospital that wants to investigate the potential of software robots. Ordina’s life sciences business unit offers each of them a customised solution. Bart Briers has been in charge of the department since October 2017. What challenges do players in the pharmaceutical, biotech and other medical sectors face? And what makes Ordina the ideal partner to offer them support?
“Compliance is one of the biggest challenges for pharmaceutical and biotech companies,” Bart starts off. “They have to fulfil highly complex rules and compliance regulations. These may be technical product requirements as well as regulations governing market access and concerning the use of big data and medical data. In addition, they have to adhere to good manufacturing and distribution practices throughout the entire chain, which also includes IT development. All companies in the sector struggle with achieving the right balance between compliance and innovation.”